Today: 9 June 2026
Oracle stock price today: ORCL heads into Tuesday reopen after 2.3% Friday rise as funding plan stays in focus
16 February 2026
1 min read

Oracle stock price today: ORCL heads into Tuesday reopen after 2.3% Friday rise as funding plan stays in focus

New York, Feb 16, 2026, 11:27 EST — The market has closed.

  • Oracle finished Friday at $160.14, gaining 2.34% on the day.
  • Presidents Day keeps U.S. markets closed Monday, with trading picking up again on Tuesday.
  • Oracle’s proposal to bankroll a hefty cloud expansion using a mix of debt and equity remains under scrutiny from investors.

Oracle finished Friday’s session 2.34% higher at $160.14. The software giant won’t resume trading until Tuesday, with the U.S. market closing for a holiday.

The timing’s notable: with U.S. markets closed for Presidents Day, trading won’t pick up again until Tuesday. Stocks and bonds both get a shortened week.

Oracle’s immediate outlook boils down to this: investors are grappling with how to value a major cloud expansion that needs significant capital, just as the wider market grows wary of hefty tech spending on artificial intelligence.

Oracle shares have pulled back hard from their 52-week peak at $345.72, as investors weigh rising Oracle Cloud Infrastructure revenues against the capital required to keep expansion going.

Oracle is targeting between $45 billion and $50 billion in new capital for 2026, aiming to boost its cloud infrastructure capacity. The company plans to tap both debt and equity markets to pull this off, it said earlier this month.

The company spelled out parts of its plan in a February 8-K, pointing to an “at-the-market” initiative that would let it sell as much as $20 billion in common stock gradually, plus a notes sale totaling $25 billion. SEC

Now, investors are zeroing in on Oracle’s ability to maintain solid cloud growth—enough to counterbalance dilution risks from stock sales and the drag of higher interest costs after taking on more debt. If AI-driven demand slows or customers push back workload plans, pressure could mount.

There’s the risk that the funding plan drags on the stock before any fresh revenue materializes, or that a steeper cost of capital squeezes Oracle’s balance sheet even more. Investors haven’t forgotten Oracle’s earnings miss and the company’s warning on increased spending back in December.

Oracle, for its part, is competing in a segment where giants—both hyperscalers and enterprise software players—are pouring billions into data centers and AI. That kind of arms race keeps investors jumpy about any hint that “build it and they will come” projections aren’t adding up.

U.S. markets are dark Monday, so the focus turns to Tuesday’s open and a busy macro calendar in the days ahead. Traders are zeroed in on what the Federal Reserve might signal about rates. Minutes from the Fed’s January 27-28 meeting are set for release Feb. 18, landing three weeks after the meeting itself.

Stock Market Today

  • Docebo (TSX:DCBO) Valuation Story Shifts Amid Revised Earnings Guidance
    June 9, 2026, 10:40 AM EDT. Docebo's fair value remains at CA$35.97 despite updated financial models, reflecting a recalibration of valuation assumptions. Analysts highlight contrasting bullish views, citing a clear growth story backed by recent revenue guidance raising full-year 2026 estimates to US$271-275 million, against bearish concerns over limited analyst coverage and potential risks. The e-learning software provider forecast revenue of approximately US$65.4-65.6 million for Q1 2026, and US$66.7-66.9 million for Q2. At its Inspire 2026 event, Docebo unveiled a next-generation learning platform and key product updates, signaling strategic progress. Investors should monitor shifting assumptions and sector context amid evolving market narratives.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes
Previous Story

Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop